← 產業報告目錄
Brain Cancer Diagnostics Market Size, Share & Trends Analysis Report By Diagnostic Technique (Imaging Techniques (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, PET Scan or PET-CT Scan, Single-photon Emission Computed Tomography (SPECT) Scan), Tissue Sampling/Biopsy, Molecular Diagnostics, Others), By Brain Cancer Type, By End-Users, By Region, And By Segment Forecasts, 2023-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-05頁數 180報告編號 INSIGHTACE-b71e9c1ef3
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2022 valuation of USD 1.46 Billion, the global Brain Cancer Diagnostics Market is expected to accelerate to USD 2.45 Billion by 2031, demonstrating a CAGR of 6.19% during the 2023–2031 forecast window.
The Brain Cancer Diagnostics sector involves dynamics.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Brain Cancer Diagnostics Market Snapshot
Chapter 4. Global Brain Cancer Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Diagnostic Technique Estimates & Trend Analysis
5.1. By Diagnostic Technique, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Diagnostic Technique:
5.2.1. Imaging Techniques
5.2.1.1. Magnetic Resonance Imaging (MRI),
5.2.1.2. Computed Tomography (CT) Scan
5.2.1.3. PET Scan or PET-CT Scan
5.2.1.4. Single-photon Emission Computed Tomography (SPECT) Scan
5.2.2. Tissue Sampling/Biopsy
5.2.3. Molecular Diagnostics
5.2.4. Others
Chapter 6. Market Segmentation 2: By Brain Cancer Type Estimates & Trend Analysis
6.1. By Brain Cancer Type & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Brain Cancer Type:
6.2.1. Gliomas
6.2.2. Meningiomas
6.2.3. Pituitary tumors
6.2.4. Others
Chapter 7. Market Segmentation 3: By End-user Estimates & Trend Analysis
7.1. By End-user & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By End-user:
7.2.1. Hospitals
7.2.2. Diagnostic Laboratories
7.2.3. Cancer Hospitals/Centers
Chapter 8. Brain Cancer Diagnostics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts By Diagnostic Technique, 2023-2031
8.1.2. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts By Brain Cancer Type, 2023-2031
8.1.3. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts By End-user, 2023-2031
8.1.4. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, 2023-2031
8.2.2. Europe Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, 2023-2031
8.2.3. Europe Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, 2023-2031
8.2.4. Europe Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, 2023-2031
8.3.2. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, 2023-2031
8.3.3. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, 2023-2031
8.3.4. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
8.4. Latin America
8.4.1. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, (US$ Million) 2023-2031
8.4.2. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, (US$ Million) 2023-2031
8.4.3. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, (US$ Million) 2023-2031
8.4.4. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, (US$ Million) 2023-2031
8.5.2. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, (US$ Million) 2023-2031
8.5.3. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, (US$ Million) 2023-2031
8.5.4. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. GE Healthcare
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. Siemens Healthineers AG
9.2.4. GE Healthcare
9.2.5. MDxHealth
9.2.6. NantOmics
9.2.7. Biocept, Inc.
9.2.8. Koninklijke Philips N.V.
9.2.9. Canon Medical Systems
9.2.10. Hitachi, Ltd.
9.2.11. Neusoft Medical Systems
9.2.12. Abbott Laboratories
9.2.13. Roche Holding AG
9.2.14. Bio Rad Laboratories Inc.
9.2.15. Illumina, Inc.
9.2.16. Bristol-Myers Squibb
9.2.17. Toshiba Medical Systems Corporation
9.2.18. Agilent Technologies Inc.
9.2.19. Hologic, Inc.
9.2.20. Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們